Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Food and Drug Administration [Docket Nos. FDA-2014-N-1069; FDA-2017-N-6931; FDA-2011-N-0362; FDA-2011-N-0279; FDA-2011-N-0672; FDA-2014-N-0913; FDA-2017-N-0493; and FDA-2011-N-0781]
 AGENCY: Food and Drug Administration, HHS.
 ACTION: Notice.
 SUMMARY: The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
 FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, 
                        *PRAStaff@fda.hhs.gov.*


SUPPLEMENTARY INFORMATION: The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at 
                    *https://www.reginfo.gov/​public/​do/​PRAMain.*
                     An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.
                    ( print page 36608) Table 1—List of Information Collections Approved by OMB
Title of collection
OMB control
                             No.
Date
                             approval 
                             expiresBlood Establishment Registration and Product Listing for Manufacturers of Human Blood and Blood Products and Licensed Devices; Form FDA 2830
0910-0052
6/30/2021Current Good Manufacturing Practices and Related Regulations for Blood and Blood Components; and Requirements for Donation Testing, Donor Notification, and “Lookback”
0910-0116
6/30/2021Current Good Manufacturing Practices for Finished Pharmaceuticals and Medical Gases
0910-0139
6/30/2021Prescription Drug Marketing
0910-0435
6/30/2021Prominent and Conspicuous Mark of Manufacturers on Single-Use Devices
0910-0577
6/30/2021Guidance FDA and Industry Procedures for Section 513(g) Requests for Information under the Federal Food, Drug, and Cosmetic Act
0910-0705
6/30/2021Utilization of Adequate Provision Among Low to Non-Internet Users
0910-0853
6/30/2021Record Retention Requirements for the Soy Protein/Coronary Heart Disease Health Claim
0910-0428
7/31/2021
 Dated: July 24, 2018. Leslie Kux, Associate Commissioner for Policy.


[FR Doc. 2018-16156 Filed 7-27-18; 8:45 am] BILLING CODE 4164-01-P